254 related articles for article (PubMed ID: 17218579)
1. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.
Villalba WO; Sampaio-Barros PD; Pereira MC; Cerqueira EM; Leme CA; Marques-Neto JF; Paschoal IA
Chest; 2007 Jan; 131(1):217-22. PubMed ID: 17218579
[TBL] [Abstract][Full Text] [Related]
2. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
[TBL] [Abstract][Full Text] [Related]
3. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
[TBL] [Abstract][Full Text] [Related]
4. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.
Golpe R; Pérez-de-Llano LA; Méndez-Marote L; Veres-Racamonde A
Respir Care; 2013 Aug; 58(8):1329-34. PubMed ID: 23322886
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
[TBL] [Abstract][Full Text] [Related]
8. Doppler echocardiogram, oxygen saturation and submaximum capacity of exercise in patients with cystic fibrosis.
Rovedder PM; Ziegler B; Pasin LR; Rampon G; Pinotti AF; de Tarso Roth Dalcin P; Menna-Barreto SS
J Cyst Fibros; 2007 Jul; 6(4):277-83. PubMed ID: 17157083
[TBL] [Abstract][Full Text] [Related]
9. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension as estimated by Doppler echocardiography in adolescent and adult patients with cystic fibrosis and their relationship with clinical, lung function and sleep findings.
Ziegler B; Perin C; Casarotto FC; Fagondes SC; Menna-Barreto SS; Dalcin PTR
Clin Respir J; 2018 Feb; 12(2):754-761. PubMed ID: 27925430
[TBL] [Abstract][Full Text] [Related]
11. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.
Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T
Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864
[TBL] [Abstract][Full Text] [Related]
12. Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.
Gadre A; Ghattas C; Han X; Wang X; Minai O; Highland KB
Lung; 2017 Oct; 195(5):529-536. PubMed ID: 28646245
[TBL] [Abstract][Full Text] [Related]
13. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.
Deuschle K; Weinert K; Becker MO; Backhaus M; Huscher D; Riemekasten G
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S53-9. PubMed ID: 21586219
[TBL] [Abstract][Full Text] [Related]
14. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test.
Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR
Ann Rheum Dis; 2007 Feb; 66(2):169-73. PubMed ID: 16868020
[TBL] [Abstract][Full Text] [Related]
15. A study on pulmonary complications of systemic sclerosis in eastern India.
Ghosh A; Banerjee A; Biswas AK
Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
17. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
[TBL] [Abstract][Full Text] [Related]
18. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
[TBL] [Abstract][Full Text] [Related]
19. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
Neal JE; Lee AS; Burger CD
Clin Respir J; 2014 Oct; 8(4):404-9. PubMed ID: 24308300
[TBL] [Abstract][Full Text] [Related]
20. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.
Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK
Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
